Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092601934> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2092601934 endingPage "296" @default.
- W2092601934 startingPage "288" @default.
- W2092601934 abstract "ObjectivesTo estimate the cost-effectiveness of cetuximab monotherapy, cetuximab plus irinotecan, and panitumumab monotherapy compared with best supportive care (BSC) for the third and subsequent lines of treatment of patients with Kirsten rat sarcoma wild-type metastatic colorectal cancer from the perspective of the UK National Health Service.MethodsAn “an area under the curve” cost-effectiveness model was developed. The clinical effectiveness evidence for both cetuximab and panitumumab was taken from a single randomized controlled trial (RCT) in each case and for cetuximab plus irinotecan from several sources.ResultsPatients are predicted to survive for approximately 6 months on BSC, 8.5 months on panitumumab, 10 months on cetuximab, and 16.5 months on cetuximab plus irinotecan.Panitumumab is dominated, and cetuximab is extended dominated. An incremental cost-effectiveness ratio (ICER) of £95,000 per quality-adjusted life-year (QALY) was estimated for cetuximab versus BSC and is likely to be relatively accurate, because the relevant clinical evidence is taken from a high-quality RCT. The estimated ICER for panitumumab versus BSC, at £187,000 per QALY, is less certain due to assumptions in the adjustment for the substantial crossing-over of patients in the RCT. The ICER for cetuximab plus irinotecan versus BSC, at £88,000 per QALY, is least certain due to substantial uncertainty about progression-free survival, treatment duration, and overall survival. Nonetheless, when key parameters are varied within plausible ranges, all three treatments always remain poor value for money.ConclusionsAll three treatments are highly unlikely to be considered cost-effective in this patient population in the United Kingdom. We explain how the reader can adapt the model for other countries." @default.
- W2092601934 created "2016-06-24" @default.
- W2092601934 creator A5034168180 @default.
- W2092601934 creator A5037428320 @default.
- W2092601934 creator A5067817683 @default.
- W2092601934 creator A5068818875 @default.
- W2092601934 creator A5081409332 @default.
- W2092601934 creator A5082727271 @default.
- W2092601934 creator A5089453687 @default.
- W2092601934 date "2013-03-01" @default.
- W2092601934 modified "2023-10-16" @default.
- W2092601934 title "Cost-Effectiveness of Cetuximab, Cetuximab Plus Irinotecan, and Panitumumab for Third and Further Lines of Treatment for KRAS Wild-Type Patients with Metastatic Colorectal Cancer" @default.
- W2092601934 cites W1979828310 @default.
- W2092601934 cites W2005947177 @default.
- W2092601934 cites W2059489931 @default.
- W2092601934 cites W2067691287 @default.
- W2092601934 cites W2072508272 @default.
- W2092601934 cites W2097121246 @default.
- W2092601934 cites W2098223440 @default.
- W2092601934 cites W2106789440 @default.
- W2092601934 cites W2120490763 @default.
- W2092601934 cites W2127113630 @default.
- W2092601934 cites W2134519717 @default.
- W2092601934 cites W2136734908 @default.
- W2092601934 cites W2142564546 @default.
- W2092601934 cites W2147718573 @default.
- W2092601934 cites W2155311724 @default.
- W2092601934 cites W2157117527 @default.
- W2092601934 cites W2157416388 @default.
- W2092601934 doi "https://doi.org/10.1016/j.jval.2012.11.001" @default.
- W2092601934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23538180" @default.
- W2092601934 hasPublicationYear "2013" @default.
- W2092601934 type Work @default.
- W2092601934 sameAs 2092601934 @default.
- W2092601934 citedByCount "36" @default.
- W2092601934 countsByYear W20926019342013 @default.
- W2092601934 countsByYear W20926019342014 @default.
- W2092601934 countsByYear W20926019342015 @default.
- W2092601934 countsByYear W20926019342016 @default.
- W2092601934 countsByYear W20926019342017 @default.
- W2092601934 countsByYear W20926019342018 @default.
- W2092601934 countsByYear W20926019342019 @default.
- W2092601934 countsByYear W20926019342020 @default.
- W2092601934 countsByYear W20926019342021 @default.
- W2092601934 countsByYear W20926019342022 @default.
- W2092601934 crossrefType "journal-article" @default.
- W2092601934 hasAuthorship W2092601934A5034168180 @default.
- W2092601934 hasAuthorship W2092601934A5037428320 @default.
- W2092601934 hasAuthorship W2092601934A5067817683 @default.
- W2092601934 hasAuthorship W2092601934A5068818875 @default.
- W2092601934 hasAuthorship W2092601934A5081409332 @default.
- W2092601934 hasAuthorship W2092601934A5082727271 @default.
- W2092601934 hasAuthorship W2092601934A5089453687 @default.
- W2092601934 hasBestOaLocation W20926019341 @default.
- W2092601934 hasConcept C121608353 @default.
- W2092601934 hasConcept C126322002 @default.
- W2092601934 hasConcept C143998085 @default.
- W2092601934 hasConcept C168563851 @default.
- W2092601934 hasConcept C2778332735 @default.
- W2092601934 hasConcept C2779998722 @default.
- W2092601934 hasConcept C2780259306 @default.
- W2092601934 hasConcept C2781187634 @default.
- W2092601934 hasConcept C526805850 @default.
- W2092601934 hasConcept C71924100 @default.
- W2092601934 hasConceptScore W2092601934C121608353 @default.
- W2092601934 hasConceptScore W2092601934C126322002 @default.
- W2092601934 hasConceptScore W2092601934C143998085 @default.
- W2092601934 hasConceptScore W2092601934C168563851 @default.
- W2092601934 hasConceptScore W2092601934C2778332735 @default.
- W2092601934 hasConceptScore W2092601934C2779998722 @default.
- W2092601934 hasConceptScore W2092601934C2780259306 @default.
- W2092601934 hasConceptScore W2092601934C2781187634 @default.
- W2092601934 hasConceptScore W2092601934C526805850 @default.
- W2092601934 hasConceptScore W2092601934C71924100 @default.
- W2092601934 hasIssue "2" @default.
- W2092601934 hasLocation W20926019341 @default.
- W2092601934 hasLocation W20926019342 @default.
- W2092601934 hasOpenAccess W2092601934 @default.
- W2092601934 hasPrimaryLocation W20926019341 @default.
- W2092601934 hasRelatedWork W1225528904 @default.
- W2092601934 hasRelatedWork W1968430623 @default.
- W2092601934 hasRelatedWork W2058934913 @default.
- W2092601934 hasRelatedWork W2088713834 @default.
- W2092601934 hasRelatedWork W2091789348 @default.
- W2092601934 hasRelatedWork W2158997283 @default.
- W2092601934 hasRelatedWork W2593180677 @default.
- W2092601934 hasRelatedWork W3116599757 @default.
- W2092601934 hasRelatedWork W3149695606 @default.
- W2092601934 hasRelatedWork W93307583 @default.
- W2092601934 hasVolume "16" @default.
- W2092601934 isParatext "false" @default.
- W2092601934 isRetracted "false" @default.
- W2092601934 magId "2092601934" @default.
- W2092601934 workType "article" @default.